A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria

PLoS Pathogens

Volumn 4, Issue 3, 2008, Pages

  Callewaert, Lien ^a   Aertsen, Abram ^a   Deckers, Daphne ^a   Vanoirbeek, Kristof G A ^a   Vanderkelen, Lise ^a   Van Herreweghe, Joris M ^a   Masschalck, Barbara ^a   Nakimbugwe, Dorothy ^a,c   Robben, Johan ^a,b   Michiels, Chris W ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; LACTOFERRIN; LYSOZYME; PERIPLASMIC LYSOZYME INHIBITOR OF C TYPE LYSOZYME; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; HEN EGG LYSOZYME; PERIPLASMIC BINDING PROTEIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL SURVIVAL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOST PATHOGEN INTERACTION; MASS SPECTROMETRY; PLASMID; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEOBACTERIA; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERITIDIS; ANIMAL; CHEMISTRY; CHICKEN; DRUG ANTAGONISM; ELECTROSPRAY MASS SPECTROMETRY; ENZYMOLOGY; GENE SILENCING; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; TANDEM MASS SPECTROMETRY;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HEDERA; NEGIBACTERIA; PROTEOBACTERIA; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHI;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; CHICKENS; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE SILENCING; GRAM-NEGATIVE BACTERIA; HUMANS; IMMUNE TOLERANCE; MURAMIDASE; PERIPLASMIC BINDING PROTEINS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERITIDIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; VIRULENCE FACTORS;

EID: 42949124018     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000019     Document Type: Article

References (41)

1. Grinde B (1989) A lysozyme isolated from rainbow trout acts on mastitis pathogens. FEMS Microbiol Lett 60(2): 179-182.
2. Nilsen IW, Øverbø K, Sandsdalen E, Sandaker E, Slettent K, et al. (1999) Protein purification and gene isolation of chlamysin, a cold-active lysozyme-like enzyme with antibacterial activity. FEBS Letters 464: 153-158.
3. Pellegrini A, Thomas U, Bramaz N, Klauser S, Hunziker P, et al. (1997) Identification and isolation of a bactericidal domain in chicken egg white lysozyme. J Appl Microbiol 82: 372-387.
4. Düring K, Porsch P, Mahn A, Brinkmann O, Gieffers W (1999) The non-enzymatic microbicidal activity of lysozymes. FEBS Letters 449: 93-100.
5. Zipperle GF, Ezzell JW, Doyle RJ (1984) Glucosamine substitution and muramidase susceptibility in Bacillus anthracis. Can J Microbiol 30: 553-559.
6. Clarke A, Dupont C (1992) O-acetylated peptidoglycan: its occurence, pathobiological significance, and biosynthesis. Can J Microbiol 38: 85-91.
7. Bera A, Herbert S, Jakob A, Vollmer W, Götz F (2005) Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 55: 778-787.
8. Fernie-King BA, Seilly DJ, Davies A, Lachmann PJ (2002) Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect Immun 70(9): 4908-4916.
9. Fernie-King BA, Seilly DJ, Binks MJ, Sriprakash KS, Lachmann PJ (2007) Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities. Microbes Infect 9: 300-307.
10. Monchois V, Abergel C, Sturgis J, Jeudy S, Claverie JM (2001) Escherichia coli ykfE ORFan gene encodes a potent inhibitor of c-type lysozyme. J Biol Chem 276: 18437-18441.
11. Deckers D, Masschalck B, Aertsen A, Callewaert L, Van Tiggelen CGM, et al. (2004) Periplasmic lysozyme inhibitor contributes to lysozyme resistance in Escherichia coli. Cell Mol Life Sci 61: 1229-1237.
12. Nakimbugwe D, Masschalck B, Deckers D, Callewaert L, Aertsen A, et al. (2006) Cell wall substrate specificity of six different lysozymes and lysozyme inhibitory activity of bacterial extracts. FEMS Microbiol Lett 259: 41-46.
13. Callewaert L, Masschalck B, Deckers D, Nakimbugwe D, Atanassova M, et al. (2005) Purification of Ivy, a lysozyme inhibitor from Escherichia coli, and characterisation of its specificity for various lysozymes. Enzyme Microb Technol 37(2): 205-211.
14. Kaufmann E, Geisler N, Weber K (1984) SDS-PAGE strongly overestimates the molecular masses of the neurofilament proteins. FEBS Lett 170(1): 81-84.
15. Schäffer AA, Aravind L, Madden TL, Shavirin S, Spouge JL, et al. (2001) Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 29(14): 2994-3005.
16. Tatusov RL, Fedorova ND, Jackson JD, Jacobs AR, Kiryutin B, et al. (2003) The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4: 41.
17. Babu MM, Priya ML, Selvan AT, Madera M, Gough J, et al. (2006) A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J Bacteriol 188: 2761-2773.
18. Abergel C, Monchois V, Byrne D, Chenivesse S, Lembo F, et al. (2007) Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in gram-negative bacteria. Proc Nat Ac Sci 104(15): 6394-6399.
19. Tokuda H, Matsuyama S-I (2004) Sorting of lipoproteins to the outer membrane in E. coli. Biochim Biophys Acta 1693: 5-13.
20. Narita S-I, Tokuda H (2007) Amino Acids at Positions 3 and 4 Determine the Membrane Specificity of Pseudomonas aeruginosa Lipoproteins. J Biol Chem 282(18): 13372-13378.
21. Revington M, Semesi A, Yee A, Arrowsmith CH, Shaw GS (2006) The solution structure of the protein ydhA from Escherichia coli. J Biomol NMR 35: 295-300.
22. Lam H-M, Winkler ME (1992) Characterization of the complex pdxH-tyrS operon of Escherichia coli K-12 and pleiotropic phenotypes caused by pdxH insertion mutations. J Bacteriol 174: 6033-6045.
23. Daigle F, Graham JE, Curtis III R (2001) Identification of Salmonella typhi genes expressed within macrophages by selective capture of transcribed sequences (SCOTS). Mol Microbiol 41(5): 1211-1222.
24. Marthur NB, Dwarkadas AM, Sharma VK, Saha K, Jain N (1990) Anti-infective factors in preterm human colostrum. Acta Paediatr Scand 79: 1039-1044.
25. Thompson AB, Bohling T, Payvandi F, Rennard SI (1990) Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med 115: 148-158.
26. Ng V, Cho P, Mak S, Lee A (2000) Variability of tear protein levels in normal young adults: between -day variation. Graefe's Arch Clin Exp Ophtalmol 238: 892-899.
27. Navarre WW, Halsey TA, Walthers D, Frye J, McClelland M, et al. (2005) Coregulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol Microbiol 56(2): 492-508.
28. Gunn JS, Alpuche-Aranda CM, Loomis WP, Belden WJ, Miller SI (1995) Characterization of the Salmonella typhimurium pagC/pagD chromosomal region. J Bacteriol 177(17): 5040-5047.
29. Uehara T, Suefuji K, Valbuena N, Meehan B, Donegan M, et al. (2005) Recycling of the anhydro-N-acetylmuramic acid derived from cell wall murein involves a two-step conversion to N-acetylglucosamine-phosphate. J Bacteriol 187(11): 3643-3649.
30. Ito Y, Yoshikawa A, Hotani I, Fukuda S, Sugimura K, et al. (1999) Amino acid sequences of lysozymes newly purified from invertebrates implay wide distribution of a novel class in the lysozyme family. Eur J Biochem 259: 456-461.
31. Nilsen IW, Myrnes B, Edvardsen RB, Chourrout D (2003) Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes. Cell Mol Life Sci 60: 2210-2218.
32. Boneca IG (2005) The role of peptidoglycan in pathogenesis. Curr Opin Microbiol 8: 46-53.
33. Traub S, von Aulock S, Hartung T, Hermann C (2006) MDP and other muropeptides - direct and synergistic effects on the immune system. J Endotoxin Res 12(2): 69-85.
34. Laemmli M (1970) Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
35. Heukeshoven J, Dernick R (1988) Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 9: 28-32.
36. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal Chem 68: 850-858.
37. Higgins D, Thompson J, Gibson T, Thompson JD, Higgins DG, et al. (1994) CLUSTAL W: improving the sensitivity of progressivemultiple sequence alignment through sequence weighting,position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
38. Blattner FR, Plunkett III G, Bloch CA, Perna NT, Burland V, et al. (1997) The complete genome sequence of Escherichia coli K-12. Science 277(5331): 1453-1462.
39. Kang Y, Durfee T, Glasner JD, Qiu Y, Frisch D, et al. (2004) Systematic Mutagenesis of the Escherichia coli Genome. J Bacteriol 186(15): 4921-4930.
40. Nicas TI, Hancock REW (1980) Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J Bacteriol 143(2): 872-878.
41. Aertsen A, Tesfazgi Mebrhatu M, Michiels CW (2008) Activation of the Salmonella Typhimurium Mrr protein. Biochem Biophys Res Commun;In press.